Á lódáil...
Rapidly decreasing level of prostate-specific antigen during initial androgen deprivation therapy is a risk factor for early progression to castration-resistant prostate cancer: A retrospective study
To build a practical model for predicting the progression to castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT). In all, 185 patients with prostate cancer who had received ADT as the primary therapy at our institution, from 2003 to 2014, were retrospectively enrolle...
Na minha lista:
Foilsithe in: | Medicine (Baltimore) |
---|---|
Main Authors: | , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Wolters Kluwer Health
2017
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6392679/ https://ncbi.nlm.nih.gov/pubmed/28885333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007823 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|